Struggling with Opioid Dependence?

Understanding Opioid Use Disorder (OUD)

Opioid Use Disorder (OUD) is a serious medical condition caused by ongoing use of opioids, whether prescription medications like oxycodone or hydrocodone, or illicit drugs such as heroin. It often includes intense cravings, physical dependence, withdrawal symptoms, and disruption to everyday life, relationships, and health. Effective treatment usually combines medication with counseling and support to manage symptoms and improve outcomes.

This clinical research study is evaluating a new injectable form of buprenorphine. Participants will receive inpatient care and a single-dose of either an approved or investigational version of the medication. The study is designed to compare how each version is processed in the body.

All study-related care is provided at no cost. This includes inpatient detox monitoring, medication to manage withdrawal symptoms if needed, and counseling and support throughout the stay.

About the Study

This clinical research study is evaluating an investigational version of an approved injectable medication (buprenorphine) used to treat opioid use disorder (OUD).

The purpose of the study is to compare how the investigational product and the approved product behave in the body to determine whether they deliver the same amount of medication into the bloodstream.

The study will last up to 7 weeks. It includes a 5-day inpatient stay for observation following the injection, followed by scheduled clinic visits and follow-up check-ins.

Participants will receive study-related physical exams, lab testing, ECGs, health questionnaires, and medical assessments. There is no cost to participate, and compensation may be available for time and travel.